StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
TG Therapeutics (TGTX) PT Lowered to $19 at Jefferies
April 19, 2022 8:36 AM
Jefferies analyst Chris Howerton lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $19.00 (from $46.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
TG Therapeutics (TGTX) PT Lowered to $23 at B.Riley
April 19, 2022 7:30 AM
TG Therapeutics (TGTX) PT Lowered to $20 at Ladenburg Thalmann
April 18, 2022 12:58 PM
Pre-Open Stock Movers 04/18: Casa Systems and Natus Medical Higher; TG Therapeutics and Nektar Lower (more...)
April 18, 2022 9:23 AM
TG Therapeutics (TGTX) PT Lowered to $20 at JPMorgan
April 18, 2022 8:32 AM
Form 8-K TG THERAPEUTICS, INC. For: Apr 15
April 18, 2022 7:30 AM
TG Therapeutics (TGTX) PT Lowered to $19 at H.C. Wainwright
April 18, 2022 6:52 AM
TG Therapeutics (TGTX) Voluntarily Withdraws BLA/sNDA for U2 to Treat Patients with CLL and SLL
April 15, 2022 8:31 AM
TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
April 15, 2022 8:30 AM
